Lifestyle Modifications are crucial in managing diabetes and obesity
Although the existing evidence in HFpEF is compelling, further trials seem warranted, particularly with respect to the effects of GLP-1 RAs on clinical outcomes and, possibly, in broader patient populations, such as patients with HFrEF or those without obesity.
Immunomodulatory activities and biomedical applications of melittin and its recent advances
A low FODMAP diet may alter the exposure of enteroendocrine cells to gut microbial metabolites, leading to altered production of GLP-1
However, its still important to be aware of the potential side effects, which may include: Stomach pain
Starting at the lowest possible dose and escalating more slowly than standard protocols helps identify tolerance issues before reaching problematic dose levels